Home › Pfizer to test Xalkori lung cancer drug with Merck immunotherapy
 

Keywords :   


Pfizer to test Xalkori lung cancer drug with Merck immunotherapy

2014-08-26 18:11:28| Biotech - Topix.net

Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in the hopes the combination will improve the outcomes for patients taking the approved Pfizer therapy.

Tags: test drug cancer lung

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
26.06Michigan Sets Record Recycling Rate in 2023, Recycles Nearly 70,000 Tons of Materials
26.06Companies Seek Federal EPR: How Producers Can Prepare
26.06Q&A with GFLs Tyler Stefure: Integrating New Fleet Tech & Upholding GFL Values
26.06SWANA Publishes Report on the Performance of Seattles Zero Waste System
26.06Baltimore Sues Major Brands for Alleged Role in Plastic Pollution Crisis
26.06Petco Aims Sight at Large-Scale Recycling Program to Divert LDPE Plastic from Landfills
26.06CloverLeaf Animal Welfare Systems expands team
26.06Disruption as airline pilots begin industrial action
More »